本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Precision Biosciences Inc

4.54
+0.19004.37%
成交量:4.13萬
成交額:18.39萬
市值:1.09億
市盈率:-0.55
高:4.60
開:4.37
低:4.27
收:4.35
52周最高:8.82
52周最低:3.53
股本:2,407.18萬
流通股本:2,282.25萬
量比:0.53
換手率:0.18%
股息:- -
股息率:- -
每股收益(TTM):-8.3225
每股收益(LYR):1.04
淨資產收益率:-205.16%
總資產收益率:-45.34%
市淨率:6.57
市盈率(LYR):4.37

資料載入中...

2026/02/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/11

重要事件披露

Form 8-K - Current report
2026/01/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/13

重要事件披露

Form 8-K - Current report
2025/12/30

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/11/12

重要事件披露

Form 8-K - Current report
2025/11/10

重要事件披露

Form 8-K - Current report
2025/11/10

[補充]招股説明書

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2025/11/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/03

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/03

重要事件披露

Form 8-K - Current report
2025/09/02

重要事件披露

Form 8-K - Current report